Thus, carriers of the ADIPOQ rs2241766 TG+GG genotype are more likely to be associated with lower adiponectin, higher IR and CRC risk compared with those carrying the wild TT genotype. This evidence concerns the gene ADIPOQ and colorectal carcinoma.